The FDA Just Rejected a Bid for MDMA to Treat PTSD

August 9, 2024 Emily Mullin

The agency has asked drugmaker Lykos Therapeutics to run an additional study on the use of the psychedelic drug in patients with post-traumatic stress disorder, pushing back its next proposal by years.

Previous Article
Google Researchers Found Nearly a Dozen Flaws in Popular Qualcomm Software for Mobile GPUs
Google Researchers Found Nearly a Dozen Flaws in Popular Qualcomm Software for Mobile GPUs

The vulnerabilities, which have been patched, may have novel appeal to attackers as an avenue to compromisi...

Next Article
Noah Lyles’ Olympic Run Is the New Normal for Living With Covid
Noah Lyles’ Olympic Run Is the New Normal for Living With Covid

Dozens of Olympic athletes competed with Covid as society increasingly treats it like the flu or the common...